Reliable Biopharmaceutical LLC Expands Manufacturing Capacity for Lithium Dodecyl Sulfate and Sodium Dodecyl Sulfate

Share Article

Reliable Biopharmaceutical LLC expands manufacturing capacity for Lithium Dodecyl Sulfate and Sodium Dodecyl Sulfate in its St. Louis, Missouri facility.

Reliable Biopharmaceutical LLC announced today that it has expanded their manufacturing capacity for Lithium Dodecyl Sulfate (Lithium Lauryl Sulfate) and Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate). Both products are manufactured in the United States at our St. Louis facility. Lithium Dodecyl Sulfate and Sodium Dodecyl Sulfate are used in the manufacture of diagnostic tests and in the pharmaceutical industry for protein isolation and purification. Also known as Dodecyl Lithium Sulfate or Lithium Lauryl Sulfate, LDS and SDS are sold both in research and bulk containers.

“Reliable continues to leverage our quality systems and proprietary purification technology to produce the highest quality excipients in the world,” said David Feldker President and CEO. “We are committed to our customer’s success and their requirement for high purity ingredients.”

About Reliable Biopharmaceutical LLC
Founded in 1968, RB is an integrated developer and manufacturer of Active Pharmaceutical Ingredients (APIs) and High Purity Ingredients (HPIs) for pharmaceuticals and biologics. RB has established a strong position as a leading developer and manufacturer of complex generic injectable APIs. The company has a number of DMFs that have been accepted by Regulatory Agencies and has more in various stages of development. RB's products are the active ingredients for leading generic injectable drugs that treat cancer, heart disease, hypertension, anxiety and other serious and life threatening illnesses. RB also manufactures critical processing aids for the pharmaceutical industry and currently supplies these products to many of the world's leading pharmaceutical and biotechnology companies.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

James Wickenhauser
Reliable Biopharmaceutical Corp.

Visit website